Merus Labs International Inc (MSLI.OQ)

MSLI.OQ

About

Merus Labs International Inc. (Merus), formerly Envoy Capital Group Inc., is a specialty pharmaceutical company. The Company is engaged in the acquisition and licensing of branded prescription pharmaceutical products. It has products in the area of urology/women's health, anti-infective, and wound care. Its products include... (more)

Buy/Sell

» Analyst Consensus

Overall

Beta:	0.80
Market Cap (Mil.):	$16.44
Shares Outstanding (Mil.):	30.71
Dividend:	--
Yield (%):	--

Financials

	MSLI.OQ	Industry	Sector
P/E (TTM):	--	35.66	35.83
EPS (TTM):	-0.64	--	--
ROI:	-38.12	19.36	18.72
ROE:	-49.48	20.07	19.54

Latest News about MSLI.OQ

» More MSLI.OQ News

Earnings vs. Estimates

Analyst Research Reports

Report Title	Price
Merus Labs International Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. Provider: Reuters Investment Profile	$20.00 Buy
Merus Labs International Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. Provider: Reuters Investment Profile	$20.00 Buy
Thomson Reuters Stock Report - MERUS LABS INTERNATIONAL INC (MSL-T) Provider: Thomson Reuters Stock Report	$25.00 Buy
Merus Labs International Inc. (MSL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Provider: GlobalData	$250.00 Buy
ValuEngine Detailed Valuation Report for MSLI Provider: ValuEngine, Inc.	$127.00 Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Related Topics:

Edition:

U.S.
- Arabic
- Argentina
- Brazil
- Canada
- China
- France
- Germany
- India
- Italy
- Japan
- Latin America
- Mexico
- Russia
- Spain
- United Kingdom

Back to top

Reuters.com

Legal

Support & Contact

Connect with Reuters

About

Our Flagship financial information platform incorporating Reuters Insider

An ultra-low latency infrastructure for electronic trading and data distribution

A connected approach to governance, risk and compliance

Our next generation legal research platform

Our global tax workstation

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.